Unknown

Dataset Information

0

TLR agonists regulate PDGF-B production and cell proliferation through TGF-beta/type I IFN crosstalk.


ABSTRACT: Transforming growth factor-beta (TGF-beta) and type I interferon (IFN) autocrine/paracrine loops are recognized as key mediators of signaling cascades that control a variety of cellular functions. Here, we describe a novel mechanism by which Toll-like receptor (TLR) agonists utilize these two autocrine/paracrine loops to differentially regulate the induction of PDGF-B, a growth factor implicated in a number of diseases ranging from tumor metastasis to glomerulonephritis. We demonstrate that CpG-specific induction of PDGF-B requires activation of Smads through TGFbeta1 autocrine/paracrine signaling. In contrast, polyinosinic:polycytidylic acid strongly represses CpG's as well as its own intrinsic ability to induce PDGF-B mRNA through type I IFN-mediated induction of Smad7, a negative regulator of Smad3/4. Furthermore, we have shown that this crosstalk mechanism translates into similar regulation of mesangial cell proliferation. Thus, our results demonstrate the importance of crosstalk between TGF-beta and type I IFNs in determining the specificity of TLR-mediated gene induction.

SUBMITTER: Chow EK 

PROVIDER: S-EPMC1356307 | biostudies-literature | 2005 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

TLR agonists regulate PDGF-B production and cell proliferation through TGF-beta/type I IFN crosstalk.

Chow Edward K EK   O'connell Ryan M RM   Schilling Stephen S   Wang Xiao-Fan XF   Fu Xin-Yuan XY   Cheng Genhong G  

The EMBO journal 20051124 23


Transforming growth factor-beta (TGF-beta) and type I interferon (IFN) autocrine/paracrine loops are recognized as key mediators of signaling cascades that control a variety of cellular functions. Here, we describe a novel mechanism by which Toll-like receptor (TLR) agonists utilize these two autocrine/paracrine loops to differentially regulate the induction of PDGF-B, a growth factor implicated in a number of diseases ranging from tumor metastasis to glomerulonephritis. We demonstrate that CpG-  ...[more]

Similar Datasets

| S-EPMC1785085 | biostudies-other
| S-EPMC4187064 | biostudies-literature
| S-EPMC2828749 | biostudies-other
| S-EPMC2700179 | biostudies-literature
2005-09-01 | GSE2706 | GEO
| S-EPMC3070925 | biostudies-literature
| S-EPMC5833743 | biostudies-literature
| S-EPMC5035883 | biostudies-literature
| S-EPMC5415450 | biostudies-literature
| S-EPMC3030728 | biostudies-literature